NCT07392060
- Conditions
- Cervical Cancer Metastatic
- Locations
-
Not specified
Clinical trial condition
Cervical Cancer Metastatic
Explore clinical trials studying Cervical Cancer Metastatic. Study availability and eligibility vary by location and protocol.
6 public trials
0 recruiting studies
Cervical Cancer Metastatic trial results
Not Yet Recruiting
A Non-interventional Registration Study of Monotherapy or Combination Regimens Based on Camrelizumab or Famitinib for the Treatment of Cervical Cancer
NCT07266350
- Conditions
- Cervical Cancer Metastatic, Cervical Cancer Recurrent
- Locations
-
Not specified
Not Yet Recruiting
A Prospective, Randomized, Parallel Trial of Famitinib Malate at Different Doses Combined With Camrelizumab for the Treatment of Recurrent and Metastatic Cervical Cancer
NCT07143292
- Conditions
- Cervical Cancer Metastatic, Cervical Cancer Recurrent
- Locations
-
Not specified
Not Yet Recruiting
QL1706 in Patients With Recurrent and Metastatic Cervical Cancer Resistant to Prior PD-1/PD-L1 Antibody Therapy
NCT07141186
- Conditions
- Cervical Adenocarcinoma, Cervical Cancer, Cervical Cancer Metastatic, +15 more
- Locations
-
Not specified
NCT07035808
- Conditions
- Cervical Cancer Metastatic, Cervical Cancer Stage IVA, Female Urogenital Diseases, +12 more
- Locations
-
Not specified
Active, Not Recruiting
SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer
NCT03614949
- Conditions
- Cervical Cancer, Cervical Cancer Metastatic, Cervical Cancer Recurrent, +13 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Ohio State University - OSUMC - Wexner Medical Center Hilliard, Ohio, United States